Phage-phage competition and biofilms affect interactions between two virulent bacteriophages and Pseudomonas

Magdalena Bürkle1, Imke H E Korf2, Anne Lippegaus3

  • 1Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.

The ISME Journal
|April 6, 2025
PubMed

Insights

Virulent phages (viruses) can reduce Pseudomonas aeruginosa, but resistance emerges. Combining phages and antibiotics is effective against biofilms, while phage competition impacts bacterial interactions.

Area of Science:

  • Microbiology
  • Virology
  • Bacteriology

Background:

  • Virulent bacteriophages (phages) are viruses that infect and lyse specific bacterial hosts.
  • Co-infection with multiple phages can alter bacterial lysis dynamics and host-phage interactions.
  • Understanding phage-bacterial interactions is crucial for phage therapy development.

Purpose of the Study:

  • To investigate factors influencing interactions between two virulent phages and Pseudomonas aeruginosa in different growth states (planktonic, cell line, biofilm).
  • To measure bacterial time-kill kinetics and individual phage replication during co-infection.
  • To identify mechanisms of phage resistance and phage-phage competition.

Main Methods:

  • Assessing bacterial viability and phage replication kinetics under single and co-administration conditions.
  • Evaluating phage efficacy against planktonic P. aeruginosa, infected lung cell cultures, and static/adherent biofilms.
  • Analyzing phage adsorption, lysis times, and emergence of phage-resistant bacterial variants.
  • Investigating the impact of meropenem antibiotic in combination with phages.

Main Results:

  • Phages effectively reduced planktonic P. aeruginosa and infected cell cultures, but resistance developed.
  • Phage combinations showed initial biofilm inhibition; sustained control required meropenem.
  • Adherent biofilms exhibited tolerance to phages and/or meropenem, indicating spatio-temporal variation.
  • A faster-lysing phage depleted resources, creating competitive disadvantage and cross-resistance in the other phage.
  • Phage-phage competition and resistance mechanisms were P. aeruginosa genotype-dependent.

Conclusions:

  • Bacterial growth state significantly influences phage efficacy and resistance emergence.
  • Phage-phage competition and bacterial genotype-dependent resistance shape phage therapy outcomes.
  • Sequential phage administration did not enhance lysis, highlighting complex interactions.